Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07218731 · ClinicalTrials.gov registry record · NA

Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses

A NA study of Presbyopia and Presbyopia Correction, sponsored by Ohio State University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07218731 is a NA study of Presbyopia and Presbyopia Correction that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 30 participants, below the 270-participant average among 38 other Presbyopia trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07218731, a NA study of Presbyopia and Presbyopia Correction, is actively recruiting participants, sponsored by Ohio State University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to assess participant experience when wearing multifocal contact lenses compared to spherical contact lenses with reading glasses.

Interventions

  • DEVICE Multifocal contact lenses
  • DEVICE Spherical contact lenses

Study Locations (1)

Ohio

  • The Ohio State University College of Optometry - Columbus

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-12-08
Est. Completion 2026-06
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT07218731

The ClinicalTrials.gov registry entry for NCT07218731 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 270-participant average among 38 other Presbyopia trials with a reported enrollment target (89% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Presbyopia appearing as the primary indexed condition, and to 2 interventions - of which Multifocal contact lenses is the first listed.

NCT07218731 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT07218731 about?

NCT07218731 is a clinical study titled "Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses". The purpose of the study is to assess participant experience when wearing multifocal contact lenses compared to spherical contact lenses with reading glasses.

What is the current status of trial NCT07218731?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-12-08. Estimated completion is 2026-06.

What conditions does trial NCT07218731 study?

This clinical trial studies the following conditions: Presbyopia, Presbyopia Correction.

What interventions are being tested in trial NCT07218731?

The interventions under investigation include: Multifocal contact lenses (DEVICE), Spherical contact lenses (DEVICE).

Who is sponsoring clinical trial NCT07218731?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07218731 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Presbyopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.